KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$0.44
+0.04 (+10.28%)
As of Feb 8, 2:28 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.88M 4.46M 5.44M
Net Income -169,945 -168,167 -171,039
EPS
Profit Margin -3.5% -3.8% -3.2%
Rev Growth -8.5% +21.3% +21.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 6.06M 5.80M 6.56M
Total Equity 7.87M 9.08M 8.18M
D/E Ratio 0.77 0.64 0.80
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -214,177 -200,655 -244,682
Free Cash Flow -155,731 -123,018 -136,236